Best Long-Term Dividend ETF: Fidelity’s FDVV vs. Schwab’s SCHD

Schwab U.S. Dividend Equity ETF (SCHD 0.83%) and Fidelity High Dividend ETF (FDVV 0.09%) present distinct differences in terms of cost, sector exposure, and recent performance metrics. Notably, FDVV has outperformed SCHD in five-year returns; however, this comes with a higher fee structure and increased volatility, which may affect investor decisions.

Both SCHD and FDVV are structured to deliver equity income, yet their investment strategies show significant divergence. SCHD follows a rules-based index that emphasizes quality U.S. dividend payers, whereas FDVV leans towards higher-yielding stocks, particularly in the technology and financial sectors. This comparison aims to clarify their cost structures, associated risks, performance outcomes, and portfolio characteristics, aiding readers in determining which ETF aligns best with their investment objectives.

Detailed Snapshot of Cost and Size Metrics

Beta is a measure of price volatility in relation to the S&P 500; it is calculated based on five-year monthly returns. The one-year return reflects the total return over the trailing 12 months.

FDVV’s higher fee structure compared to SCHD makes SCHD a more cost-effective option for investors. Additionally, SCHD boasts a better dividend yield, which is particularly attractive for those prioritizing income generation in their investment portfolios.

In-Depth Performance and Risk Comparison of ETFs

What Holdings are Inside Each ETF?

FDVV is specifically designed to achieve a high dividend yield, showcasing a strong tilt towards the technology sector (26%), financial services (18%), and the consumer cyclical sector (15%) among its 119 holdings. Key positions in this fund include Nvidia, Apple, and Microsoft. With a robust 10-year track record, FDVV demonstrates consistent performance without any unusual features or quirks that may concern investors.

Conversely, SCHD allocates a larger portion of its assets to sectors such as consumer defensive, healthcare, and energy, thereby establishing a contrasting risk profile and income generation strategy. Its leading holdings, including Texas Instruments, UnitedHealth, and Merck, embody a defensive investment strategy, contributing to its lower volatility and higher yield in comparison to FDVV.

For comprehensive insights on ETF investing, refer to the full guide available at this link.

Implications of These ETFs for Investors

It is essential to note that both dividend ETFs are commendable options for investors seeking solid returns. Since their market introductions, SCHD and FDVV have achieved annualized total returns of 13.1% and 13.2%, respectively, while experiencing relatively minimal drawdowns. Both ETFs feature reasonable expense ratios, with dividend yields exceeding 3% and a diversified portfolio of over 100 stocks, which enhances stability and reduces risk.

However, if I had to choose between the two, my preference would lean slightly towards SCHD due to its lesser reliance on the technology sector. This choice stems from my personal investment strategy, as I already have substantial exposure to major tech stocks and prefer to avoid over-concentration in that area. Conversely, for another investor, the technology focus of FDVV could be a compelling reason to choose it, particularly given that these tech giants have significantly boosted FDVV’s performance over the last five years.

This contrast illustrates that while both ETFs are viable options for U.S. dividend stocks, investors must evaluate which one integrates more effectively into their portfolio strategy. Ultimately, my inclination is towards SCHD, owing to its superior dividend yield, slightly lower expense ratio, reduced five-year drawdown, and its emphasis on consumer defensive, healthcare, and energy sectors, which I am less exposed to. For those who favor large tech companies, FDVV may indeed be the better fit. If you prioritize stability and efficiency, SCHD could be the optimal choice.